Amman, July 5 (Petra) -- Hikma Pharmaceuticals has donated an emergency shipment of medicines worth $1 million to support relief efforts for people affected by the recent twin earthquakes in Venezuela ...

A ruling in favor of generic drugmaker Hikma will make it harder for brand-name manufacturers to block cheaper alternatives.

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Hikma Pharmaceuticals PLC (LON:HIK) is about to go ...

Misuse is common. Liability is conditional.

Hikma Pharmaceuticals PLC (LON:HIK) investors will be delighted, with the company turning in some strong numbers with its latest results. Hikma Pharmaceuticals beat earnings, with revenues hitting ...

Hikma has obtained permission from the Food and Drug Administration for a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin, under the brand name Tyzavan ...

Hikma Pharmaceuticals ( (GB:HIK)) has provided an update. Hikma Pharmaceuticals has continued the second tranche of its $250 million share buyback, repurchasing its own ordinary shares between 22 and ...

LONDON, April 17, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug Application ...

Hikma Pharmaceuticals USA will invest $1 billion by 2030 to further expand its U.S. manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines ...

Takeda suffered a defeat in its battle to keep a competitor to its version of an ancient gout drug off the market. A federal court backed Hikma's right to sell a med with the same active ingredient as ...